Investors & Media

Whats new.

Press releases

Press releases.

Immutep Enters into Clinical Trial Collaboration, Service and Supply Agreement with Cytlimic

January 7th 2019
press releases

Immutep Announces US$5.2 Million Financing Led by U.S. Specialist Healthcare Investor, Altium Capital

December 19th 2018
press releases

Immutep Secures European Patent for Eftilagimod Alpha in Combination with Therapeutic Antibodies for Treating Cancer

November 29th 2018
press releases

Investor updates

Investor updates.

Investor Update - January 2019

January 31st 2019
investor updates

Investor Update - June 2018

June 19th 2018
investor updates

Investor Update - December 2017

December 21st 2017
investor updates

Analyst reports

Analyst reports.

goetzpartners securities - 2019 a decisive year rich in news flow

This research report is intended for use only by persons who qualify as professional investors or eligible counterparties (institutional investors) in the applicable jurisdiction, and not by any private individuals or other persons who qualify as retail clients.

February 5th 2019
analyst reports

Maxim - Provides Update- Catalysts Ahead in 2019 in Several Programs around LAG-3

February 1st 2019
analyst reports

Maxim - More TACTI-mel Data Presented at the Annual ICI Europe Summit

November 27th 2018
analyst reports